This includes: (1) the hexanucleotide repeat expansion in C9ORF72 gene (C9-ALS) and (2) the pathogenic variants in the SOD1 gene (SOD1-ALS), and (3) it has also driven the research of biomarkers associated with pathological products caused by the mutation. This evidence concerns the gene SOD1 and amyotrophic lateral sclerosis.